These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38254953)

  • 1. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
    Zhai Y; Shen H; Wei H
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of CD34
    Li XP; Zhang WN; Mao JY; Zhao BT; Jiang L; Gao Y
    J Transl Med; 2022 Aug; 20(1):359. PubMed ID: 35962395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
    Lai Y; Sheng L; Wang J; Zhou M; OuYang G
    Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value.
    Li D; Liang J; Yang W; Guo W; Song W; Zhang W; Wu X; He B
    Front Oncol; 2022; 12():876981. PubMed ID: 35957912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic insights and immune microenvironment delineation in acute myeloid leukemia by ferroptosis-derived signature.
    Jing L; Zhang B; Sun J; Feng J; Fu D
    Heliyon; 2024 Mar; 10(6):e28237. PubMed ID: 38532996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.
    Deng C; Zeng T; Zhu P; Zhao S; Huang Z; Huang W; Zhang W; Huang X; Fu L
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10015-10025. PubMed ID: 37258721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia.
    Chen M; Tao Y; Yue P; Guo F; Yan X
    BMC Genom Data; 2022 Dec; 23(1):85. PubMed ID: 36550404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
    Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
    Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia.
    Xie KY; Chen SZ; Wang Y; Zeng ML; Liu XY; Liang Y; Wei J
    Transl Cancer Res; 2023 Dec; 12(12):3693-3702. PubMed ID: 38192996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.
    Huang R; Liao X; Li Q
    Onco Targets Ther; 2017; 10():5243-5254. PubMed ID: 29138577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia.
    Zhang X; Zhang X; Liu K; Li W; Wang J; Liu P; Ma W
    Cancer Med; 2022 Dec; 11(24):5050-5065. PubMed ID: 35535739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
    Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia.
    Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y
    Front Immunol; 2024; 15():1417398. PubMed ID: 38966636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
    Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
    Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
    Zhu R; Tao H; Lin W; Tang L; Hu Y
    Front Oncol; 2020; 10():574939. PubMed ID: 33330048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a SASP-related prognostic signature in patients with acute myeloid leukaemia.
    Li MF; Zhang DH; Wang LS; Yue CF; Pang LJ; Guo YM; Yang ZG
    J Cell Mol Med; 2024 Aug; 28(16):e70017. PubMed ID: 39159071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.